DIABETES NEW ZEALAND, NEW ZEALAND SOCIETY FOR THE STUDY OF DIABETES, EDGAR DIABETES & OBESITY RESEARCH CENTRE AND HEALTHIER LIVES-HE ORANGA HAUORA NATIONAL SCIENCE CHALLENGE
We collectively urge the New Zealand Government to support Pharmac to fully fund Continuous Glucose Monitoring (CGM) technology for all New Zealanders living on insulin to improve health outcomes and promote equitable care for people with diabetes.
Glucose monitoring is one of the most difficult and intrusive parts of living with diabetes. CGM technology offers people with diabetes less painful and less disruptive ways of monitoring blood glucose levels. CGM improves glucose control and quality of life, reduces diabetes distress and saves lives, and is the basic standard of care worldwide.
CGM is cost effective and allows for precision management in diabetes. Better overall glucose levels provide the opportunity to reduce the risk of complications such as stroke, cardiovascular disease, renal failure, lower limb amputations and blindness.
On behalf of all New Zealanders with diabetes and their whānau, we ask the Government for full funding for:
These actions will promote equitable health outcomes for
Māori, Pacific, and low-income New Zealanders.